help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cunha, C. d. F.
Right arrow Articles by Finch, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunha, C. d. F.
Right arrow Articles by Finch, F. L.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 6 2797-2802
Copyright © 2004 by The Endocrine Society

Early Adrenocortical Recovery after Glucocorticoid Therapy in Children with Leukemia

Cristiane de Freitas Cunha, Ivani Novato Silva and Francisca Lee Finch

Division of Pediatric Endocrinology, University Hospital, Federal University of Minas Gerais, 30130-100 Belo Horizonte, Minas Gerais, Brazil

Address all correspondence and requests for reprints to: Ivani Novato Silva, M.D., Pediatric Department, University Hospital, Federal University of Minas Gerais, Avenida Alfredo Balena 190, s/4061 30130-100 Belo Horizonte, Minas Gerais, Brazil. E-mail: ivanins{at}medicina.ufmg.br.

The duration of glucocorticoid-induced inhibition that occurs in the hypothalamic-pituitary-adrenal (HPA) axis after discontinuation of treatment is controversial. The main objective of this prospective study was to evaluate the inhibition of the HPA axis by dexamethasone in children and adolescents with acute lymphoid leukemia. Thirty-five patients (median age of 6.9 yr) were evaluated. A stimulus test with ovine CRH (1 µg/kg) was performed before the introduction of dexamethasone (6 mg/m2·d for 28 d), in the 8th and 28th days of glucocorticoid therapy, and 48 h and 1 month after discontinuation of glucocorticoid therapy. Suppression of the basal secretion as well as the maximum concentration of ACTH occurred during glucocorticoid therapy (P < 0.01). The pituitary function before the introduction of dexamethasone was similar to the one seen 48 h and 1 month after withdrawing it. Suppression of the adrenal function was detected during glucocorticoid therapy, which persisted for 48 h after the steroid was removed from treatment (P < 0.01). One month after ceasing the administration of the glucocorticoid, the adrenal function was similar to that before glucocorticoid therapy. According to these results, a clinical and laboratory follow-up of the HPA axis in the month after the cessation of dexamethasone therapy is suggested to determine glucocorticoid replacement.

This work was supported by Fundação de Amparo à pesquisa do Estado de Minas Gerais.

Abbreviations: ALL, Acute lymphoid leukemia; HPA, hypothalamic-pituitary-adrenal; ITT, insulin tolerance test; oCRH, ovine CRH.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society